413 related articles for article (PubMed ID: 31054246)
1. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.
Couch DG; Tasker C; Theophilidou E; Lund JN; O'Sullivan SE
Clin Sci (Lond); 2017 Nov; 131(21):2611-2626. PubMed ID: 28954820
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
4. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
7. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin.
Maghfour J; Rietcheck H; Szeto MD; Rundle CW; Sivesind TE; Dellavalle RP; Lio P; Dunnick CA; Fernandez J; Yardley H
Clin Exp Dermatol; 2021 Dec; 46(8):1518-1529. PubMed ID: 34022073
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.
Alhamoruni A; Lee AC; Wright KL; Larvin M; O'Sullivan SE
J Pharmacol Exp Ther; 2010 Oct; 335(1):92-102. PubMed ID: 20592049
[TBL] [Abstract][Full Text] [Related]
10. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance.
Borrelli F; Izzo AA
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):33-49. PubMed ID: 19285259
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.
Petrosino S; Schiano Moriello A; Cerrato S; Fusco M; Puigdemont A; De Petrocellis L; Di Marzo V
Br J Pharmacol; 2016 Apr; 173(7):1154-62. PubMed ID: 25598150
[TBL] [Abstract][Full Text] [Related]
12. Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats.
Marichal-Cancino BA; González-Hernández A; MaassenVanDenBrink A; Ramírez-San Juan E; Villalón CM
J Vasc Res; 2020; 57(3):152-163. PubMed ID: 32248195
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB
Karwad MA; Couch DG; Wright KL; Tufarelli C; Larvin M; Lund J; O'Sullivan SE
Biochem Pharmacol; 2019 Oct; 168():465-472. PubMed ID: 31325449
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.
Sarnelli G; D'Alessandro A; Iuvone T; Capoccia E; Gigli S; Pesce M; Seguella L; Nobile N; Aprea G; Maione F; de Palma GD; Cuomo R; Steardo L; Esposito G
PLoS One; 2016; 11(5):e0156198. PubMed ID: 27219328
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway.
Sarnelli G; Gigli S; Capoccia E; Iuvone T; Cirillo C; Seguella L; Nobile N; D'Alessandro A; Pesce M; Steardo L; Cuomo R; Esposito G
Phytother Res; 2016 Jun; 30(6):963-70. PubMed ID: 26929026
[TBL] [Abstract][Full Text] [Related]
16. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
[TBL] [Abstract][Full Text] [Related]
17. Protective role of palmitoylethanolamide in contact allergic dermatitis.
Petrosino S; Cristino L; Karsak M; Gaffal E; Ueda N; Tüting T; Bisogno T; De Filippis D; D'Amico A; Saturnino C; Orlando P; Zimmer A; Iuvone T; Di Marzo V
Allergy; 2010 Jun; 65(6):698-711. PubMed ID: 19909294
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.
Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V
J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.
Hind WH; England TJ; O'Sullivan SE
Br J Pharmacol; 2016 Mar; 173(5):815-25. PubMed ID: 26497782
[TBL] [Abstract][Full Text] [Related]
20. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
